MedPath

AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Commercialized
Register Number

85304

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jul 29, 2020

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number85304
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (3)

AMLODIPINO BESILATOActive
Quantity: 6,94 mg
Name: AMLODIPINO BESILATO
HIDROCLOROTIAZIDAActive
Quantity: 12,5 mg
Name: HIDROCLOROTIAZIDA
VALSARTANActive
Quantity: 160 mg
Name: VALSARTAN

ATC CLASSIFICATION (3)

C09D
C09DX
C09DX01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.